Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Popper

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Pathology|December 22, 2010
Chlamydia psittaci Infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesionsAriane Aigelsreiter, Tanja Gerlza, Alexander J A Deutsch, et al.
Translational Lung Cancer Research|March 15, 2021
Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinomaYu Tian, Peiwei Li, Zhaohua Xiao, et al.
Cancer Medicine|December 29, 2017
AKT3 drives adenoid cystic carcinoma development in salivary glandsKatalin Zboray, Julian Mohrherr, Patricia Stiedl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancerNermine S Kamal, Jean-Charles Soria, Jean Mendiboure, et al.
Molecular Oncology|February 6, 2014
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancerXiaoli Ma, Vanessa Rousseau, Haiji Sun, et al.
Virchows Archiv : an International Journal of Pathology|October 30, 2008
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomasSanja Dacic, Hannelore Kothmaier, Stephanie Land, et al.
American Journal of Respiratory Cell and Molecular Biology|October 25, 2011
Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilationYingji Li, Michelle Connolly, Chandran Nagaraj, et al.
Plos One|May 29, 2015
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Wolfgang Hilbe, Georg Pall, Florian Kocher, et al.
Archives of Pathology & Laboratory Medicine|March 4, 2010
Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology societyVictor L Roggli, Allen R Gibbs, Richard Attanoos, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outsKen A Olaussen, Julien Adam, Elsa Vanhecke, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Pathology|December 22, 2010
Chlamydia psittaci Infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesionsAriane Aigelsreiter, Tanja Gerlza, Alexander J A Deutsch, et al.
Translational Lung Cancer Research|March 15, 2021
Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinomaYu Tian, Peiwei Li, Zhaohua Xiao, et al.
Cancer Medicine|December 29, 2017
AKT3 drives adenoid cystic carcinoma development in salivary glandsKatalin Zboray, Julian Mohrherr, Patricia Stiedl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancerNermine S Kamal, Jean-Charles Soria, Jean Mendiboure, et al.
Molecular Oncology|February 6, 2014
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancerXiaoli Ma, Vanessa Rousseau, Haiji Sun, et al.
Virchows Archiv : an International Journal of Pathology|October 30, 2008
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomasSanja Dacic, Hannelore Kothmaier, Stephanie Land, et al.
American Journal of Respiratory Cell and Molecular Biology|October 25, 2011
Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilationYingji Li, Michelle Connolly, Chandran Nagaraj, et al.
Plos One|May 29, 2015
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Wolfgang Hilbe, Georg Pall, Florian Kocher, et al.
Archives of Pathology & Laboratory Medicine|March 4, 2010
Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology societyVictor L Roggli, Allen R Gibbs, Richard Attanoos, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outsKen A Olaussen, Julien Adam, Elsa Vanhecke, et al.
Pageof 7